PainReform Ltd. (PRFX) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
PainReform Ltd. (PRFX) Bundle
Discover the true worth of PainReform Ltd. (PRFX) with our advanced DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate how changes influence the valuation of PainReform Ltd. (PRFX) – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | -100 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -.7 | -1.7 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | -10295.35 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 17.44 | 100 | 83.49 | 83.49 | 83.49 | 83.49 | 83.49 |
| EBIT | -.7 | -1.7 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | -10312.79 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | .9 | 15.7 | 16.5 | 4.1 | 8.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .1 | .2 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 63.95 | 100 | 92.79 | 92.79 | 92.79 | 92.79 | 92.79 |
| Inventories | .0 | 2.0 | 2.2 | 7.8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 9096.51 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .0 | .7 | .1 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 243.02 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | -6.98 | 100 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 |
| Tax Rate, % | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 |
| EBITAT | -1.0 | -1.8 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.0 | -3.1 | -8.2 | -14.2 | -1.7 | -.2 | .0 | .0 | .0 | .0 |
| WACC, % | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | 8 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | 35.86 |
What You Will Get
- Editable Forecast Inputs: Flexibly adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: PainReform Ltd.'s (PRFX) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life PRFX Financials: Pre-filled historical and projected data for PainReform Ltd.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate PainReform’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize PainReform’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered PainReform data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for PainReform’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose PainReform Ltd. (PRFX) Calculator?
- Precision: Utilizes accurate PainReform financial data for reliable results.
- Customizable: Allows users to adjust and test various inputs effortlessly.
- Efficiency: Avoid the complexity of creating a financial model from the ground up.
- Expert-Level: Crafted with the precision and usability expected by industry leaders.
- Intuitive: Simple to navigate, suitable for users with varying levels of financial expertise.
Who Should Use PainReform Ltd. (PRFX)?
- Healthcare Professionals: Understand the latest advancements in pain management therapies and their applications.
- Researchers: Utilize innovative models in your studies related to pain treatment methodologies.
- Investors: Evaluate your investment strategies by analyzing market trends and performance of PainReform Ltd. (PRFX).
- Pharmaceutical Analysts: Enhance your analysis with a comprehensive understanding of the pain management sector.
- Patients and Advocates: Gain insights into emerging treatments and their potential impact on pain relief.
What the Template Contains
- Preloaded PRFX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.